Quest Diagnostics (Ibrutinib Royalty Rights) is Other Pharmaceuticals and Biotechnology in United States that focus on cancer therapy business. They cover business area such as Provider, diagnostic information service, holder, drug-royalty right, commercialization, ibrutinib.
Other Pharmaceuticals and Biotechnology
-
Cancer Therapy
-
Secaucus, NJ
United States
Private
Providerdiagnostic information serviceholderdrug-royalty rightcommercializationibrutinib
* We use standard office opening hours in near Quest Diagnostics (Ibrutinib Royalty Rights)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Quest Diagnostics (Ibrutinib Royalty Rights) is Other Pharmaceuticals and Biotechnology business from United States that founded in - ( years old in ), Quest Diagnostics (Ibrutinib Royalty Rights) business is focusing on Cancer Therapy.
Quest Diagnostics (Ibrutinib Royalty Rights) headquarter office and corporate office address is located in Secaucus, NJ United States.
Quest Diagnostics (Ibrutinib Royalty Rights) was founded in United States.
In , Quest Diagnostics (Ibrutinib Royalty Rights) is currently focus on cancer therapy sector.
Above is snippet of Google Trends for "cancer therapy" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Quest Diagnostics (Ibrutinib Royalty Rights), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
